I review

a web of animal and human data that tightens the noose around the hypothesis that copper toxicity is causing the epidemic of Alzheimer’s disease and loss of cognition in our aging population.”
“The HLA-G (human leukocyte antigen-G) molecule plays a pivotal role in immune tolerance by inhibiting different cell subsets involved in both innate and adaptive immunity. Besides its primary function in maintaining the maternal-fetal tolerance, HLA-G has been involved in a wide range of pathological conditions where it can be either favorable or detrimental to the patient, depending on the nature of the pathology. Although several studies have demonstrated the utmost importance of the 30 untranslated region (3′UTR) in the HLA-G expression profile, limited data exist on the sequence variability of this gene HSP990 region in human populations. In this study, we characterized the genetic diversity and haplotype structure of the HLA-G 3′UTR by resequencing 444 individuals Cytoskeletal Signaling inhibitor from three sub-Saharan African populations and retrieving data from the 1000 Genomes project and the literature. A total of

1936 individuals representing 21 worldwide populations were combined and jointly analyzed. Our data revealed a high level of nucleotide diversity, an excess of intermediate frequency variants and an extremely low population differentiation, strongly supporting a history of balancing selection at this locus. The 14-bp insertion/deletion polymorphism was further pointed out as the likely target of selection, emphasizing its potential role in the post-transcriptional regulation of HLA-G expression.”
“Aim of the study: The aim of the study was to evaluate the effectiveness of postoperative radiotherapy in prostate cancer patients with unfavorable prognostic factors.\n\nMaterial and

methods: In the years 2002-2008, 121 consecutive prostate Tariquidar inhibitor cancer patients underwent radical prostatectomy and postoperative radiotherapy. The median dose was 64 Gy (range 60-72 Gy). Biochemical and clinical progression free survival were estimated. Univariate and multivariate analyses were used to analyze clinicopathological varibales associated with treatment failure.\n\nResults: The median follow-up was 27 months. Three-year bPFS was 72%. On univariate analysis it was influenced by extracapsular tumor extension (60% vs. 75%, p = 0.0232), seminal vesicles invasion (52% vs. 85%, p = 0.00041), Gleason score >= 7 (65% vs. 86%, p = 0.044) and the use of hormonal therapy (50% vs. 80%, p = 0.0058). On multivariate analysis bPFS was associated with: TNM stage (HR = 2.6), total irradiation dose (HR = 0.82) and the maximum pretreatment level of prostate-specific antigen (PSA) (HR = 0.95). Three-year cPFS was 84%. On univariate analysis it was influenced by preoperative PSA level > 10 ng/ml (75% vs. 90%, p = 0.04), vascular nerve bundles involvement (63% vs. 88%, p = 0.0031), adjacent organs infiltration (50% vs. 85%, p = 0.